By week 52, PINP levels had returned to their initial values in all groups ( Fig
This may promote faster satiety and greater satisfaction between meals
Furthermore, practical and technical barrierssuch as the need for specialized equipment, expertise, and high costslimit the widespread adoption of omics analyses, creating a gap between research findings and bedside applications
Four, resmetirom confers significant advantages to patient cohorts who do not meet the indication of GLP-1 therapies, including individuals who have already attained weight reduction and populations not afflicted with diabetes
Dr Abhayaratna has received honoraria and/or consulting fees from Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Novartis, and Novo Nordisk